In the Media

2/29/16

Ian Massey Interviewed by Stock News Now at the Source Capital 2016 Disruptive Growth & Healthcare Conference in New York City, NY

2/26/16

Pittsburgh Post-Gazette's David Templeton interviews Dr. Michael C. Munin, principal investigator at UPMC; Dr. Stephen Huhn, StemCells, Inc. CMO and VP of Clinical Research; and Michael Fraser, study participant.

12/02/15

Martin McGlynn and Stephen Huhn speak with Moira Gunn of BioTech Nation on NPR about StemCells Inc.'s recent spinal cord injury data

12/02/15

Martin McGlynn and Stephen Huhn speak with Moira Gunn of BioTech Nation on NPR about StemCells Inc.'s recent spinal cord injury data - Transcript

10/15/14

Martin McGlynn Interviewed on BioTech Nation Radio​

6/26/14

Martin McGlynn Interviewed on BioWorld Today

4/26/14

Dr. Stephen Huhn Interviewed on KCBS Radio​

2/5/14

StemCells, Inc. featured on Business News Network.  (StemCells segment starts at 3:50 into the video​)

1/13/14

StemCells, Inc. Technology is Featured in Canadian TV Broadcast

10/12/12

ABC 7 News
"Bay Area stem cell researchers see encouraging results"

10/10/12

Transplanted Neural Stem Cells Produced Myelin, UCSF Study Shows

10/10/12
Neural Stem Cell Engraftment and Myelination in the Human Brain
10/10/12
Human Neural Stem Cells Induce Functional Myelination in Mice with Severe Dysmyelination
04/2012 StemCells, Inc. Collaborators, Aileen Anderson and Brian Cummings Interviewed in April 2012 Issue of UCI's Online Magazine, ZotZine
1/30/12 Age-Related Macular Degeneration Pre-clinical Data Published in the European Journal of Neuroscience
11/17/11 UCSF's David Rowitch on Myelin Disorders - NPR
09/23/11 StemCells, Inc. CEO Martin McGlynn Featured on Wall Street Reporter
04/12/11 StemBook - Harvard Stem Cell Institute
"First Human Trials of Embryonic Stem Cell-based Therapies Head to the Clinic"

03/01/11

ABC 7 News Video
"Bay Area Company to Launch Unique Stem Cell Trial"

02/11/11

"Pace Picks Up for Clinical Trials to Evaluate Stem Cell Therapies"

12/07/10

"StemCells Snags Swissmedic Okay to Start Neural Stem Cell Trial in Spinal Cord Injury"

12/06/10 "StemCells Wins Ok for Spinal Cord Trial"

10/13/10

Link to Media“Therapeutic Promise of Human Neural Stem Cells”

08/20/10

Link to Media“Human Neural Stem Cells Restore Motor Function in Mice with Chronic Spinal Cord Injury”

08/19/10

Link to Media“StemCells, Inc. Shares Jump After News of Promising Paralysis Study”

08/18/10

Link to Media“Cell Treatment Helps Mice Long After Spine Injury”

06/23/10

MIT Technology Review

“Cell Transplants for Macular Degeneration”

03/19/10

Link to Media“StemCells, Inc. Shifts Approach to Therapies”

10/19/09

Link to Media“Stem Cell Transplants Stalled Blindness in Rats”

Please Note

Links provided may open web pages or documents that are hosted by third parties and are not maintained by StemCells, Inc. and to which our Privacy Policy does not apply. These links are provided to you for convenience and do not serve as an endorsement by StemCells, Inc. of any information or contacts that you may find on these third party sites.

Media Contacts

StemCells, Inc.

Investor Relations  (E-mail)
+1 (510) 456-4128

Email Signup

We invite you to join our mailing lists: